Impact of 5 α‐reductase inhibitor and α‐blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality
BJU International, EarlyView.
Source: BJU International - Category: Urology & Nephrology Authors: Maria I. Van Rompay,
J. Curtis Nickel,
Gayatri Ranganathan,
Philip W. Kantoff,
Keith R. Solomon,
Jennifer L. Lund,
John B. McKinlay Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Prostate Cancer | Urology & Nephrology